GN-037

· GEN İlaç ve Sağlık Ürünleri A.Ş.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GN-037, covering 2025-07-16 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis [Phase 2]